Published: April 13, 2023
Since the worldwide spread of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), treating taste and saliva secretory disorders associated disease 2019 (COVID-19) has become one most critical issues in COVID-19 era. The aim present study was to update information on treatments being applicable such oral symptoms discuss their pathogenic mechanisms. Promising include different types methods using tetracycline, corticosteroid, zinc, stellate ganglion block, phytochemical curcumin, traditional herbal medicine, nutraceutical vitamin D, photobiomodulation, antiviral drug, malic acid sialagogue, chewing gum, acupuncture, and/or moxibustion. At present, however, fully validated are still lacking for COVID-19-associated ageusia/dysgeusia/hypogeusia xerostomia/dry mouth/hyposalivation. An appropriately selected treatment healthcare should be provided patients survivors suffering from disorders. Understanding currently available options is required dental profes-sionals because they not only experience who were infected SARS-CoV-2 or recov-ered but first aware abnormal salivary secretion. By doing so, dentists hygienists can play a crucial role managing contribute improving health-related quality life relevant patients.
Language: Английский